economybharat.com

We Can Cover You
Click here
Facebook Twitter Youtube
13
13

Institute

Abu Dhabi’s Technology Innovation Institute Inaugurates Open-Source AI Summit with Critical Discussions on the Future of AI OG_NewsReleaseCompanyLogo_92655.jpg

Abu Dhabi’s Technology Innovation Institute Inaugurates Open-Source AI Summit with Critical Discussions on the Future of AI

creativebharatgroup@gmail.com November 27, 2024
Abu Dhabi, United Arab Emirates:   The Open-Source AI Summit Abu Dhabi, hosted...
Read More Read more about Abu Dhabi’s Technology Innovation Institute Inaugurates Open-Source AI Summit with Critical Discussions on the Future of AI
Ahmedabad University, IIT Gandhinagar, and UC San Diego Consortium Partners with GIFT City to Launch GIFT International Fintech Institute ahmedabad-university-official-logo.png

Ahmedabad University, IIT Gandhinagar, and UC San Diego Consortium Partners with GIFT City to Launch GIFT International Fintech Institute

creativebharatgroup@gmail.com November 15, 2024
India’s economic transformation in the 21st century is linked to the growth of our economy, significant...
Read More Read more about Ahmedabad University, IIT Gandhinagar, and UC San Diego Consortium Partners with GIFT City to Launch GIFT International Fintech Institute
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen OG_Companylog_92449.jpg

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

creativebharatgroup@gmail.com November 14, 2024
MUMBAI, India & HYDERABAD, India:  PopVax, an Indian full-stack biotechnology company developing novel...
Read More Read more about PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen